Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.
Open Access
- 1 December 1992
- journal article
- abstracts
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 267 (36) , 26031-26037
- https://doi.org/10.1016/s0021-9258(18)35712-0
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cellsPublished by Elsevier ,2004
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsPublished by Elsevier ,2004
- Release of cell surface‐associated basic fibroblast growth factor by glycosylphosphatidylinositol‐specific phospholipase CJournal of Cellular Physiology, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan.The Journal of cell biology, 1991
- Proteoheparan Sulfates Contribute to the Binding of Basic FGF to its High Affinity Receptors on Bovine Adrenocortical CellsGrowth Factors, 1991
- Signal transduction by receptors with tyrosine kinase activityPublished by Elsevier ,1990
- Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.The Journal of cell biology, 1990
- Heparin protects basic and acidic FGF from inactivationJournal of Cellular Physiology, 1986
- PEROXIDASE-LABELED ANTIBODY A NEW METHOD OF CONJUGATIONJournal of Histochemistry & Cytochemistry, 1974